News
Serina Therapeutics, Inc. ("Serina") (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate, SER-252, for advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback